Sarah Anne Kremen MD
Staff Physician/Director of Behavioral Neurology Division, The Jona Goldrich Center for Alzheimer's and Memory Disorders, Cedars-Sinai Medical Center
Join to View Full Profile
127 S. San Vicente Blvd#A6600Los Angeles, CA 90048
Phone+1 310-423-6472
Fax+1 310-423-0148
Dr. Kremen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board-certified behavioral neurologist with an interest in clinical care, clinical research, and public outreach and education. I see patients with neurodegenerative conditions, epilepsy, stroke, and other conditions that cause changes in language, memory, visual spatial, and frontal executive functioning. I am an experienced site PI for industry and academic clinical trials and observational studies of Alzheimer's disease. I also led the UCLA California Alzheimer's Disease Center for over 5 years. I am a member of the Medical Scientific Board of Alzheimer's Los Angeles.
Education & Training
VA Greater Los Angeles Healthcare SystemFellowship, Special Fellowship In Geriatric Neurology, 2009 - 2010- VA Greater Los Angeles HealthcareNeuropsychiatry and Behavioral Neurology, 2007 - 2009
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 2004 - 2007- UCLA-VA Greater Los AngelesInternship, Internal Medicine, 2003 - 2004
University of Maryland School of MedicineClass of 2003
Certifications & Licensure
CA State Medical License 2004 - 2026
American Board of Psychiatry and Neurology Neurology
UCNSBehavioral Neurology and Neuropsychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease Start of enrollment: 2012 Oct 05
- Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
- Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019) Start of enrollment: 2013 Nov 05
Publications & Presentations
PubMed
- A Multicomponent Approach to Screening for Dementia in Older Hospitalized Patients.Zaldy S Tan, Nabeel Qureshi, Nancy L Sicotte, Drew Hirsch, Cameron Escovedo
Journal of the American Geriatrics Society. 2026-04-01 - Characteristics of Dementia Care Provided by Nurse Practitioners: Findings From the Cedars-Sinai C.A.R.E.S. Program.Nabeel Qureshi, Drew Hirsch, Deana Rhinehart, Dyane Gatmaitan, Sarah Kremen
Journal of the American Geriatrics Society. 2026-03-01 - Urinary tract infection-related delirium in Alzheimer's disease and related dementias: Clinical challenges and translational opportunities.Sarah Kim, Sarah Kremen, Itai Danovitch, Shouri Lahiri
Alzheimer's & Dementia. 2026-02-01
Press Mentions
Cedars-Sinai Experts Are Available to Discuss the Complex Neurodegenerative Disorder That Caused Civil Rights Leader the Rev. Jesse Jackson to Be HospitalizedNovember 14th, 2025- Alzheimer’s Disease: The Complexities of Clinical TrialsAugust 11th, 2025
- Cedars-Sinai Neuro Experts Share Findings at Alzheimer’s ConferenceJuly 24th, 2025
Grant Support
- Alzheimer’s Disease Center of California at UCLACalifornia Department of Public Health/Alzheimer’s Disease Program2015–2021
Professional Memberships
- Member
Other Languages
- French, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
